Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 32001-32050 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06433869
The Efficacy of Bevacizumab and Serplulimab Combined With Recombinant Mutant HumanTumor Necrosis Factor(rmhTNF-NC) in the Treatment of Malignant Ascites
PHASE2Recruiting
60 participants
Started: Dec 14, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor3 locations
NCT06537960
Interest of Late Images for the Assessment of Extensions in 18FGD PET-CT of Muscle-Invasive Bladder Cancers
NARecruiting
66 participants
Started: Dec 14, 2023 · Completed: Mar 15, 2027
2 conditions1 sponsor1 location
NCT06123962
ALI/ARDS Clinical Sub-phenotyping Study
N/ARecruiting
1,500 participants
Started: Dec 14, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05977907
Neoadjuvant Pembrolizumab and IO102-103 for Squamous Cell Carcinoma of the Head and Neck (SCCHN).
PHASE2Recruiting
15 participants
Started: Dec 14, 2023 · Completed: Oct 16, 2028
1 condition3 sponsors5 locations
NCT06168604
Evaluating the Efficacy of the Pain Identification and Communication Toolkit
NARecruiting
440 participants
Started: Dec 14, 2023 · Completed: Feb 29, 2028
5 conditions2 sponsors1 location
NCT05890365
Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals
N/ARecruiting
300 participants
Started: Dec 14, 2023 · Completed: Aug 31, 2025
2 conditions3 sponsors1 location
NCT06154356
Action Observation and Motor Imagery Therapy in Parkinson's Disease
NARecruiting
54 participants
Started: Dec 14, 2023 · Completed: Dec 30, 2024
1 condition2 sponsors1 location
NCT06146790
Evaluation of Endovascular Treatment in Acute Intracranial Distal Medium Vessel Occlusion Stroke
NARecruiting
564 participants
Started: Dec 14, 2023 · Completed: Mar 1, 2026
2 conditions1 sponsor1 location
NCT05946213
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
PHASE3Recruiting
1,209 participants
Started: Dec 14, 2023 · Completed: Mar 31, 2036
3 conditions1 sponsor345 locations
NCT06178614
A Study of JNJ-87890387 for Advanced Solid Tumors
PHASE1Recruiting
200 participants
Started: Dec 14, 2023 · Completed: Jul 21, 2028
1 condition1 sponsor6 locations
NCT05175885
Ex Vivo Normothermic Perfusion in Kidney Transplantation.
NARecruiting
100 participants
Started: Dec 14, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06572215
DYNAMic Renal Assessment: NOvel Methods to Assess KIDNEY Functional Reserve
N/ARecruiting
44 participants
Started: Dec 14, 2023 · Completed: Jan 1, 2025
1 condition2 sponsors1 location
NCT05761015
Helping Osteoarthritis Patients to Walk With NSAID
PHASE4Recruiting
55 participants
Started: Dec 14, 2023 · Completed: Nov 1, 2025
3 conditions10 sponsors1 location
NCT06204172
Intensive Neurowave Emotional Stimulation (INES)
NARecruiting
40 participants
Started: Dec 14, 2023 · Completed: Sep 15, 2025
1 condition1 sponsor1 location
NCT06214858
The Safety, Tolerability, Pharmacokinetics and Food Effects of SHEN211 Tablet in Healthy Subjects
PHASE1Recruiting
76 participants
Started: Dec 14, 2023 · Completed: Apr 30, 2024
1 condition1 sponsor1 location
NCT05946824
This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned.
PHASE2Recruiting
80 participants
Started: Dec 14, 2023 · Completed: Nov 24, 2028
1 condition2 sponsors1 location
NCT05560659
Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy
PHASE2Recruiting
92 participants
Started: Dec 14, 2023 · Completed: May 31, 2027
1 condition2 sponsors3 locations
NCT04981730
The Development and Evaluation of a Web-based Childbirth and Parenting Intervention Program
NARecruiting
600 participants
Started: Dec 14, 2023 · Completed: Oct 14, 2025
3 conditions1 sponsor1 location
NCT06149819
Chest Pain Nurse Track
NARecruiting
182 participants
Started: Dec 14, 2023 · Completed: Dec 20, 2025
1 condition1 sponsor1 location
NCT05981911
Evaluation of Effectiveness and Safety of Xience Skypoint Stents in Routine Clinical Practice
N/ARecruiting
2,000 participants
Started: Dec 14, 2023 · Completed: Feb 28, 2026
1 condition2 sponsors1 location
NCT06129864
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
PHASE3Recruiting
1,145 participants
Started: Dec 14, 2023 · Completed: Sep 12, 2030
1 condition1 sponsor294 locations
NCT05929222
Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi
PHASE3Recruiting
190 participants
Started: Dec 14, 2023 · Completed: Apr 30, 2031
1 condition1 sponsor48 locations
NCT05231629
Sequential Therapy in Multiple Myeloma Guided by MRD Assessments
PHASE2Recruiting
300 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2027
1 condition3 sponsors10 locations
NCT06407271
Effect of Abutment Configuration on Peri-implant Soft and Hard Tissue in the Esthetic Zone - Randomized Clinical Trial
NARecruiting
30 participants
Started: Dec 13, 2023 · Completed: Dec 30, 2028
2 conditions2 sponsors1 location
NCT06183268
Evaluation of Radiobiological Effects in Skin Toxicities Head and Neck Cancer Patients With PBS Proton Therapy
NARecruiting
100 participants
Started: Dec 13, 2023 · Completed: Jan 2, 2030
3 conditions1 sponsor1 location
NCT06295302
A Study to Explore the Efficacy and Safety of HWH486 in Adults With Chronic Spontaneous Urticaria
PHASE2Recruiting
120 participants
Started: Dec 13, 2023 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT06123884
BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer
PHASE2/PHASE3Recruiting
526 participants
Started: Dec 13, 2023 · Completed: Jan 31, 2027
1 condition1 sponsor1 location
NCT06183021
The Effect of Cryotherapy on the Outcome of Pulpotomy and Root Canal Treatment
NARecruiting
144 participants
Started: Dec 13, 2023 · Completed: Dec 1, 2025
3 conditions1 sponsor1 location
NCT06127446
The Registry of Genetic Alterations of Taiwan Ovarian Cancer
N/ARecruiting
300 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2031
1 condition9 sponsors8 locations
NCT06088030
Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric Cancer
PHASE2Recruiting
50 participants
Started: Dec 13, 2023 · Completed: Dec 14, 2031
3 conditions2 sponsors1 location
NCT04907136
Developing and Testing Health Warning Labels on the ENDS Device
NARecruiting
210 participants
Started: Dec 13, 2023 · Completed: Apr 30, 2026
1 condition2 sponsors1 location
NCT06575881
Defining the Risk of Ventricular Tachycardia in Genetic Cardiomyopathies
N/ARecruiting
200 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2029
3 conditions1 sponsor1 location
NCT05837104
Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar Disorder
PHASE2Recruiting
40 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT06185192
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
NARecruiting
100 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06128629
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
PHASE3Recruiting
765 participants
Started: Dec 13, 2023 · Completed: Apr 30, 2028
1 condition2 sponsors132 locations
NCT04322734
Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders
N/ARecruiting
500 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2028
6 conditions2 sponsors2 locations
NCT06274710
ODYSSEE Kidney Health Trial
NARecruiting
344 participants
Started: Dec 13, 2023 · Completed: Apr 13, 2026
1 condition4 sponsors1 location
NCT06315296
An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung Cancer
NARecruiting
60 participants
Started: Dec 13, 2023 · Completed: Jun 30, 2028
5 conditions1 sponsor1 location
NCT06003348
Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones
PHASE4Recruiting
25 participants
Started: Dec 13, 2023 · Completed: Aug 31, 2028
1 condition1 sponsor1 location
NCT06136559
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
PHASE3Recruiting
1,200 participants
Started: Dec 13, 2023 · Completed: Sep 7, 2032
2 conditions1 sponsor189 locations
NCT05734105
A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib
PHASE3Recruiting
54 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor70 locations
NCT06647459
Defining the Risk of Ventricular Tachycardia in Genetic Forms of Early-onset Atrial Fibrillation
N/ARecruiting
200 participants
Started: Dec 13, 2023 · Completed: Jan 1, 2027
2 conditions1 sponsor1 location
NCT06263075
Hemodynamic Monitoring During Craniosynostosis Surgery: Comparing Traditional and Newer Technology Monitors (CRASY-PRAM)
N/ARecruiting
30 participants
Started: Dec 13, 2023 · Completed: Jun 30, 2026
4 conditions1 sponsor1 location
NCT05603273
Non-weight Bearing Exercise for Accelerated Healing of Diabetic Foot Ulcers
NARecruiting
40 participants
Started: Dec 13, 2023 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT07037888
Efficacy of Ketorolac for Postoperative Pain Management in Hip Arthroscopy: A Prospective Double-Blinded Randomized Controlled Trial
PHASE4Recruiting
100 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06064591
Host Immune and Metabolic Determinants of Sexual Conversion in Plasmodium Parasites IMMETASEX
N/ARecruiting
430 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2026
3 conditions6 sponsors3 locations
NCT04924270
Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases
PHASE2Recruiting
200 participants
Started: Dec 13, 2023 · Completed: Dec 31, 2026
6 conditions3 sponsors1 location
NCT06168266
Effects of Eccentric Exercise Training in Patients With COPD
NARecruiting
170 participants
Started: Dec 13, 2023 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT06011109
Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
PHASE1/PHASE2Recruiting
30 participants
Started: Dec 13, 2023 · Completed: Jan 31, 2026
2 conditions1 sponsor2 locations
NCT06021925
Obstetrical History and Anti-HLA Antibodies Level
N/ARecruiting
6,000 participants
Started: Dec 13, 2023 · Completed: Jun 13, 2024
2 conditions2 sponsors1 location